MS
Insider
Mark E Strome
DirectorMark E Strome (Director) filed 4 Form 4 reports in the trailing twelve months (3 purchases, 1 sale, 2 filed past the two-business-day deadline), most often in ZIVO. Across 3 priced purchase filings, the average 21-session return was +30.5% from execution and +81.2% from disclosure (delay-adjusted; derived). The largest single filing was $895K of BEAT (250,000 sh × $3.58, as filed), executed Dec 17 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+30.5%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+81.2%
same 3 filings, from disclosure
Filings, ttm
4
3 buys · 1 sells · 2 late
Median delay
5d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Apr 17
Filed Apr 24
Impact on $10,000 · 12M
$19,449 (+94.5%)
S&P 500 $10,907 (+9.1%) · 85.4 pts ahead
Mark E Strome
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $2.8M
Sells $895K
Shares × price, as filed · by filing month · past 24 months
Most traded names
ZIVO
ZIVO
4 buys · 0 sells
4 filings
BEAT
BEAT
1 buy · 1 sell
2 filings
Recent filings
ZIVOPURCHASE
Zivo Bioscience, Inc.
View filing →
$200K100,000 sh × $2.00
Exec Apr 17
Filed Apr 24 · 6:16 PM ET † BEATPURCHASE HeartBeam, Inc. View filing → $600K
750,000 sh × $0.80
Exec Apr 16
Filed Apr 16 · 8:46 PM ET ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $195K
20,000 sh × $9.77
Exec Feb 12
Filed Feb 17 · 6:22 AM ET BEATSALE HeartBeam, Inc. View filing → $895K
250,000 sh × $3.58
Exec Dec 17 2025
Filed Dec 22 2025 · 5:30 PM ET † ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $250K
20,259 sh × $12.34
Exec Oct 13 2025
Filed Oct 20 2025 · 4:19 PM ET † ZIVOPURCHASE Zivo Bioscience, Inc. View filing → $1.5M
75,000 sh × $20.19
Exec Dec 26 2024
Filed Dec 31 2024 · 5:30 PM ET †